Sfoglia per Autore
“Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study”
2004-01-01 PALMERI S
L’anemia nel paziente oncologico
2004-01-01 PALMERI S; SAVERSA; LSALVAGNO
”L’associazione di gemcitabina e docetaxel nel trattamento del carcinoma mammario metastatico”
2004-01-01 D GRASSO; PALMERI S; ARICCARDI; M DANOVA
The effectiveness of the topical use of 0,2% glyceryl trinitrate to decrease post –hemorrhoidectomy pain and to improve wounds healing.
2004-01-01 MACCHIARELLA B; PATTI R; ARCARA M; PADRONAGGIO D; BONVENTRE S; ANGILERI M; SALERNO R; ROMANO P; BUSCEMI S; DI VITA G; Palmeri, S.
“I tumori di origine sconosciuta”
2004-01-01 MVAGLICA; PALMERI S; M DANOVA
“Unexpectedly high survival rate in very poor prognosis stage III B breast cancer patients receiving cisplatin-based primary chemotherapy. A multicenter Italian study”
2004-01-01 M T IONTA; A SCANU; F ATZORI; D VACCA; A CONTU; A FARRIS; V LORUSSO; PALMERI S; L MINERBA; B MASSIDDA
“Weekly regimen of cisplatin, epirubicin, 5-Fluorouracil and folinic acid with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: a phase II study”
2004-01-01 PALMERI, S; MACALUSO, MC ; SCIUME, C; CAJOZZO, M; VAGLICA, M; MANUGUERRA, G; DI CARLO, GP; SCHITTONE, L; BINI, G; RAIMONDI, C; IANNITTO, E; ABBADESSA, V; Cajozzo, M
Analisi della frequenza del polimorfismo 1249-1250insACAA del gene TGF-beta2 in un gruppo di pazienti affette da carcinoma della mammella.
2005-01-01 NUZZO D; SCOLA L; CANDORE G; DI NOTO L; BONGIOVANNI A; VAGLICA M; CRIVELLO A; FORTE GI; GIACALONE A; CARUSO C; LIO D; PALMERI S; Scola, L.
“Carcinoma mammario metastatico: quali farmaci in seconda linea?”
2005-01-01 PALMERI S; M VAGLICA
F3 the advantage of ultrasound-guided FNA of pleura in the diagnosis of the malignant pleural effusion
2005-01-01 CAJOZZO M; COCCHIARA G; BARTOLOTTA T; ROMEO M; RENDA A; ALTIERI G; VAGLICA R; PALMERI S; MODICA G
“Erlotinib”
2005-01-01 PALMERI S; VAGLICA M
“Analysis of interleukin 10 (IL-10)-1082 G/A single nucleotide polymorphism (SNP) genotypes in breast cancer (BC) patients (pts) and in >95 years old cancer free women"
2005-01-01 PALMERI S; DLIO; MVAGLICA; ACRIVELLO; E VASSALLO; GIFORTE MCMACALUSO; CRAIMONDI; AACCARDO; CCARUSO
“Oxaliplatin plus high dose folinic acid and 5-fluoruracil i.v. bolus (OXAFAFU) versus irinotecan plus high dose folinic acid and 5-fluoruracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group trial 0103”
2005-01-01 PASQUALE COMELLA; BRUNO MASSIDDA; GIANFRANCO FILIPPELLI; PALMERI S; DONATO NATALE; ANTONIO FARRIS; FERNANDO DE VITA; FRANCO BUZZI; SALVATORE TAFUTO; LUIGI MAIORINO; SERGIO MANCARELLA; SILVANA LEO; VITO LORUSSO; LUIGI DE LUCIA; MARIO ROSELLI
“A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer”
2005-01-01 DE PLACIDO S; DE LAURENTIIS M; DE LENA M; LORUSSO V; PARADISO A; DAPRILE M; PISTILLUCCI G; FARRIS A; SAROBBA MG; PALAZZO S; MANZIONE L; ADAMO V; PALMERI S; FERRAU F; LAURIA R; PAGLIARULO C; PETRELLA G; LIMITE G; COSTANZO R; BIANCO AR
"Weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: results of a phase II study”
2005-01-01 PALMERI S; MC MACALUSO; MVAGLICA; GMODICA; LDI NOTO; GDI VITA; CSCIUM; GVETRI; EVASSALLO; GDI GES
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium”
2005-01-01 LORUSSO V; CRUCITTA E; SILVESTRIS N; ROSATI G; MANZIONE L; DE LENA M; PALMERI S; GEBBIA V; MANCARELLA S; SOBRERO A; PEZZELLA G; COMELLA P; MANGIAMELI A; MUCI D; ITALIAN BLADDER CANCER GROUP
“Breast conservation therapy as a safe and effective alternative to mastectomy for selected T4 patients treated with primary chemotherapy as part of multimodality approach”
2005-01-01 MIONTA; ASCANU; GMASIA; AMCARTA; ACONTU; AFARRIS; AMCATINO; PALMERI S; LMINERBA; BMASSIDDA
“Weekly docetaxel and gemcitabine as first line treatment for metastatic breast cancer: results of a multicenter phase II study”
2005-01-01 PALMERI, S; VAGLICA, M; SPADA, S; FILIPPELLI, G; FARRIS, A; PALMERI, L; MASSIDDA, B; MISINO, A; FERRAU', F; COMELLA, G; LEONARDI, V; CONDEMI, G; MANGIAMELI, A; DE CATALDIS, G; MACALUSO, MC; CAJOZZO, M; IANNITTO, E; DANOVA, M
”Biweekly oxaliplatin combined with ral Capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients. A Southern Italy Cooperative Oncology Group phase II study”
2005-01-01 P COMELLA; BMASSIDDA; PALMERI S; AFARRIS; LDE LUCIA; DNATALE; LMAIORINO; STAFUTO; GDE CATALDIS; RCASARETTI
“Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer:the IGCS-COL multicentre, randomised, phase III study”
2005-01-01 SDE PLACIDO; MLOPEZ; CCARLOMAGNO; GPAOLETTI; SPALAZZO; LMANZIONE; CIANNACE; GP IANNIELLO; FDE VITA; CFICORELLA; AFARRIS; GPISTILLUCCI; MGEMINI; E CORTESI; VADAMO; NGEBBIA; PALMERI S; CGALLO; FPERRONE; GPERSICO; AR BIANCO
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile